1 trial result announced this day (US Eastern).
| Time (ET) | Drug / result | Company | Outcome | Before | 24h later | 24h move |
|---|---|---|---|---|---|---|
| 7:15 AM | RGX-202 Duchenne Muscular Dystrophy | REGENXBIO (RGNX) | Met | $10.04 | $6.21 | −38.15% |
For information only. Not investment or medical advice. Prices are historical, from consolidated market data, and may contain errors. Always check the original source.